Purchase Order 75F40120P00044
Award Date 1/10/20
Potential Completion Date 3/8/23
Potential Value $137K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $212,705.80 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The purchase order is for Illumina MiSeq service contracts to support the FDA's microbial genomics program, which requires the maintenance of 10 MiSeq sequencing instruments to perform bacterial foodborne pathogen genome sequencing, targeted gene sequencing, and...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and related products, for the provision of a MiSeq sequencing instrument and a one-year preventative maintenance agreement. The total potential value of this contract is $109,857.00. Illumina has a history of providing sequencing systems and services to support genomic research and diagnostics across various federal...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $114,681.00 contract is for the delivery of a MiSeq System, a high-throughput next-generation DNA sequencing platform used to support life science research, applied markets, and molecular diagnostics. This award does not have a set-aside designation. Illumina has a history of providing...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the delivery of 3 Illumina MiSeq sequencing systems. The $284,971.50 contract has an April 30, 2019 completion date and does not use any set-aside provisions. Illumina has a history of providing sequencing equipment and consumables to support genomic research and diagnostics at various federal...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $87,870.00 contract is for the provision of a MiSeq DNA sequencing system and related consumables. The award has no set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents, to provide a MiSEQ SYSTEM. The $152,792.00 contract has no set-aside designation. Illumina has previously been awarded prime contracts by other federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans...
- The Department of Health and Human Services Food and Drug Administration awarded a $474,577.44 firm fixed price purchase order for preventive maintenance and repair services for Illumina, Inc.'s MiSeq DNA sequencing systems. The contract was awarded on December 4, 2017 with a completion date of December 5, 2019. Illumina is a manufacturer of a range of genetic and genomic analysis instruments and reagents, and has provided similar products and services to support research and diagnostics at...
- The Department of Health and Human Services Food and Drug Administration awarded a $457,531.00 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the delivery of an ILLUMINA NEXTSEQ 2000 SEQUENCING SYSTEM, plus a preventative maintenance agreement, to be performed in Silver Spring, Maryland. This award does not have a set-aside designation. Illumina has a history of providing sequencing systems and related...
- The Food and Drug Administration awarded a delivery order valued at $81,810 to Illumina, Inc. for a MiSeq instrument on March 16, 2015, with completion scheduled for September 13, 2017. This firm fixed-price delivery order, placed without set-aside designation, procures one of Illumina's established DNA sequencing platforms commonly used in genomic research and diagnostic applications. The MiSeq system is a mid-throughput sequencing instrument suitable for targeted sequencing projects, microbial...
- This federal contract award by the Department of Health and Human Services Food and Drug Administration adds $110,510.96 in funding to an original requisition with Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract is a firm fixed price Delivery Order with no set-aside designation. Illumina has previously provided sequencing systems, consumables, and support services to various government agencies for research and diagnostics. This award likely supports...